A cooperative circumstance has slowly been made among domestic and foreign pharmaceutical companies against the Real Transaction Drug Price Reduction

While the ‘second movement’ has been raised to delay and improve the ‘Real Transaction Drug Price Reduction,’ the Korea Pharmaceutical Manufacturers Association(KPMA) and the KRPIA(Korea Research-based Pharma Industry Association) seem to cooperate with each other. They have judged there is limitation if they make individual actions on each association.

According to the industry concerned, the...